Show results for
Refine by
Testing Services Targeting To Preclinical Studies Equipment Supplied In Europe
76 equipment items found
Manufactured by:Anaveon AG based inBasel, SWITZERLAND
The culmination of our research is ANV419, which is in clinical development. It is a rationally engineered fusion protein that is a stable, antibody-like molecule. ...
Manufactured by:CTIBiotech based inMeyzieu, FRANCE
Using the latest tools in bioengeneering, our researchers are now printing cancer tissues in 3D. These models can be used for highly significant pre-clinical trials and can be produced in 6/48/96 well plates for high throughput ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
A new in silico tool for early screening of compounds multicurrent blocking effects on a population of hiPSC-derived ...
Manufactured by:iThera Medical GmbH based inMunich, GERMANY
The RSOM Explorer P50 consists of a compact mobile cart system with a light-tight imaging chamber including a live-view camera for experiment supervision and a heated animal bed with integrated anesthesia supply. While raster-scanning the field of view, a nanosecond pulsed 532 nm laser excites the tissue. The induced ultrasound signal is detected by a broadband transducer with 50 MHz center ...
Manufactured by:Medprin Biotech GmbH based inFrankfurt, GERMANY
100% absorbable within 7-14 days. Hemostasis in capillary, venous as well as small artery bleeding. StypCel™ works when ligation or other conventional methods are impracticable or ...
by:XELTIS BV based inEindhoven, NETHERLANDS
The aXess graft is a restorative, synthetic, electrospun blood vessel for arteriovenous hemodialyisis access, overtime turning into a living vessel made of patient’s own ...
Manufactured by:BioCydex based inPoitiers, FRANCE
Vectisol® is dedicated to the preservation of organs, tissues and cells. This molecular complex limits the deleterious effects of the ischemia-reperfusion ...
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
Development of Bentrio™ (AM-301) has been completed. The product has been introduced to the market, starting in selected countries of the European ...
Manufactured by:ZIND Verfahrenstechnik based inMainz, GERMANY
At pilot stage, the primary membrane candidate has been chosen, as process parameters. Typically at this stage, the production method is being verified and production materials produced for toxicology or pre-clinical trials and predictable scalability is imperative. In order to facilitate the manufacturing life cycle of a successful therapeutic candidate, cGMP manufacturing needs to begin at ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-121 targets respiratory syncytial virus (RSV), a major cause of viral pneumonia for which no vaccine has been FDA approved. IVX-121 incorporates a stabilized prefusion F antigen licensed from NIAID/NIH (DS-Cav1; Science 2019). RSV F is known to undergo major structural changes that allow viral entry into the host cell, and during that process, critical protective epitopes are lost. Protein ...
Manufactured by:Wolfmet based inManchester, UNITED KINGDOM
Wolfmet 3D, developed by M&I Materials Ltd, leverages a sophisticated selective laser melting (SLM) technique for additive manufacturing. This process involves the use of a high-powered laser to meticulously fuse layers of pure tungsten powder. The result is the creation of highly intricate and precise components such as collimators and radiation shields used in medical imaging systems like ...
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
AM-125 for the treatment of vertigo is expected to complete its Phase 2 TRAVERS trial in Q2 2022 and to move into Phase 3 in Q4 2022. Keyzilen® (AM-101) for the treatment of acute inner ear tinnitus and Sonsuvi® (AM-111) for the treatment of acute inner ear hearing loss have both been evaluated in Phase 3 trials, but will require further clinical testing. ...
Manufactured by:PlasmidFactory GmbH & Co. KG based inBielefeld, GERMANY
Plasmid DNA in reproducible and certified quality for preclinical and veterinary research. Cultivation without use of animal derived media. Controlled removal of bacterial LPS endotoxins. Complete removal of RNA and proteins. A large number of quality tests already inclusive – without any additional ...
Manufactured by:Novo Nordisk A/S based inBagsværd, DENMARK
Our proprietary GalXC technology leverages a naturally occurring biologic process, ribonucleic acid interference, RNAi, to create therapies that silence disease-causing genes. This platform enables Dicerna to create molecules that can effectively interfere with the RNAi processes that lead to defective or misregulated proteins that cause disease. ...
by:XELTIS BV based inEindhoven, NETHERLANDS
Fully synthetic restorative pulmonary heart valve for Right Ventricular Outflow Tract reconstruction, overtime turning into a living heart valve made of patient’s own ...
Manufactured by:Enterome based inParis, FRANCE
New generation of oral bioactives to treat inflammatory and autoimmune diseases. EndoMimicsTM are first-in-class orally available bioactives drugs based on proteins secreted by the gut bacteria that act like human hormones or cytokines. Enterome expects partnering to play a central in generating value from its EndoMimics pipeline. ...
Manufactured by:eTheRNA based inNiel, BELGIUM
Therapeutic area: cancer vaccines; Systemic, intravenous (IV) ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
K-NK00X: Kiadis is evaluating preclinical programs with K-NK-cell therapies for the treatment of hematologic and solid ...
Manufactured by:Brenus Pharma based inIssoire, FRANCE
An allogeneic first in class immunotherapy harnessing the patient immune system to fight immune tolerance and prevent cancer ...
Manufactured by:Kuros Biosciences A.G. based inSchlieren, SWITZERLAND
MagnetOs isn’t like other bone grafts. It grows bone even in soft tissue thanks to our unique NeedleGrip™ surface technology which provides traction for our body’s vitally important ‘pro-healing’ immune cells (M2 macrophages).*†6,7 This in turn, unlocks previously untapped potential to stimulate stem cells – and form new bone throughout the graft.*8-10 ...